Tenax Therapeutics | DEFA14A: Others
Tenax Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rich Stuart
Tenax Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Giordano Christopher Thomas
Tenax Therapeutics | 10-Q: Quarterly report
Tenax Therapeutics | 8-K: Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Tenax Therapeutics | ARS: Annual Report to Security Holders
Tenax Therapeutics | DEFA14A: Others
Tenax Therapeutics | DEF 14A: Definitive information statements
Tenax Therapeutics | EFFECT: Others
Tenax Therapeutics | EFFECT: Others
Tenax Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Tenax Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Tenax Therapeutics | 10-K: Annual report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 424B3: Prospectus
Tenax Therapeutics | 424B3: Prospectus
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 424B3: Prospectus
Tenax Therapeutics | 424B3: Prospectus
Tenax Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-S.H.N. Financial Investments Ltd.(5.6%)
No Data